{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T04:32:24Z","timestamp":1789446744395,"version":"build-2803163510"},"reference-count":59,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T00:00:00Z","timestamp":1517443200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T00:00:00Z","timestamp":1517443200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["jpet.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"published-print":{"date-parts":[[2018,2]]},"DOI":"10.1124\/jpet.117.245332","type":"journal-article","created":{"date-parts":[[2017,12,4]],"date-time":"2017-12-04T16:30:23Z","timestamp":1512405023000},"page":"229-237","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Dimethoxy-etomidate: A Nonhypnotic Etomidate Analog that Potently Inhibits Steroidogenesis"],"prefix":"10.1016","volume":"364","author":[{"given":"Megan","family":"McGrath","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Celena","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Douglas E.","family":"Raines","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1124\/jpet.117.245332_bib1","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1530\/EJE-12-0921","article-title":"Long-term remission and recurrence rates in Cushing\u2019s disease: predictive factors in a single-centre study","volume":"168","author":"Alexandraki","year":"2013","journal-title":"Eur J Endocrinol"},{"key":"10.1124\/jpet.117.245332_bib2","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1111\/j.1365-2265.1985.tb03241.x","article-title":"Effect of a single bolus of etomidate upon eight major corticosteroid hormones and plasma ACTH","volume":"22","author":"Allolio","year":"1985","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1124\/jpet.117.245332_bib3","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1007\/s40618-016-0462-4","article-title":"Role of \u201cold\u201d pharmacological agents in the treatment of Cushing\u2019s syndrome","volume":"39","author":"Ambrogio","year":"2016","journal-title":"J Endocrinol Invest"},{"key":"10.1124\/jpet.117.245332_bib4","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1111\/j.1365-2265.2005.02380.x","article-title":"Long-term remission rates after pituitary surgery for Cushing\u2019s disease: the need for long-term surveillance","volume":"63","author":"Atkinson","year":"2005","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1124\/jpet.117.245332_bib5","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0028-3908(03)00144-8","article-title":"The in vitro and in vivo enantioselectivity of etomidate implicates the GABAA receptor in general anaesthesia","volume":"45","author":"Belelli","year":"2003","journal-title":"Neuropharmacology"},{"key":"10.1124\/jpet.117.245332_bib6","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1021\/mp3006227","article-title":"[(3)H]metyrapol and 4-[(131)i]iodometomidate label overlapping, but not identical, binding sites on rat adrenal membranes","volume":"10","author":"Berger","year":"2013","journal-title":"Mol Pharm"},{"key":"10.1124\/jpet.117.245332_bib7","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1097\/ALN.0000000000000416","article-title":"Advancing novel anesthetics: pharmacodynamic and pharmacokinetic studies of cyclopropyl-methoxycarbonyl metomidate in dogs","volume":"121","author":"Campagna","year":"2014","journal-title":"Anesthesiology"},{"key":"10.1124\/jpet.117.245332_bib8","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1210\/jc.2013-3628","article-title":"Ketoconazole in Cushing\u2019s disease: is it worth a try?","volume":"99","author":"Castinetti","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1124\/jpet.117.245332_bib9","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1097\/ALN.0b013e3181cf40ed","article-title":"Carboetomidate: a pyrrole analog of etomidate designed not to suppress adrenocortical function","volume":"112","author":"Cotten","year":"2010","journal-title":"Anesthesiology"},{"key":"10.1124\/jpet.117.245332_bib10","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1097\/ALN.0b013e3181ae63d1","article-title":"Methoxycarbonyl-etomidate: a novel rapidly metabolized and ultra-short-acting etomidate analogue that does not produce prolonged adrenocortical suppression","volume":"111","author":"Cotten","year":"2009","journal-title":"Anesthesiology"},{"key":"10.1124\/jpet.117.245332_bib11","first-page":"337","article-title":"Relation of the inhibition of cortisol synthesis in vivo to plasma etomidate concentrations","volume":"37","author":"Crozier","year":"1988","journal-title":"Anaesthesist"},{"key":"10.1124\/jpet.117.245332_bib12","doi-asserted-by":"crossref","first-page":"R19","DOI":"10.1530\/JOE-14-0300","article-title":"Treatment of Cushing\u2019s disease: a mechanistic update","volume":"223","author":"Cuevas-Ramos","year":"2014","journal-title":"J Endocrinol"},{"key":"10.1124\/jpet.117.245332_bib13","doi-asserted-by":"crossref","first-page":"R263","DOI":"10.1530\/EJE-14-1014","article-title":"Therapy of endocrine disease: steroidogenesis enzyme inhibitors in Cushing\u2019s syndrome","volume":"172","author":"Daniel","year":"2015","journal-title":"Eur J Endocrinol"},{"key":"10.1124\/jpet.117.245332_bib14","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1210\/jcem-59-6-1143","article-title":"Etomidate suppresses adrenocortical function by inhibition of 11 \u03b2-hydroxylation","volume":"59","author":"de Jong","year":"1984","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1124\/jpet.117.245332_bib15","doi-asserted-by":"crossref","first-page":"2277","DOI":"10.1210\/jc.2012-3582","article-title":"Multisystem morbidity and mortality in Cushing\u2019s syndrome: a cohort study","volume":"98","author":"Dekkers","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1124\/jpet.117.245332_bib16","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1530\/EJE-13-0634","article-title":"Long-term remission and recurrence rates after first and second transsphenoidal surgery for Cushing\u2019s disease: care reality in the Munich metropolitan region","volume":"170","author":"Dimopoulou","year":"2013","journal-title":"Eur J Endocrinol"},{"key":"10.1124\/jpet.117.245332_bib17","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1097\/00000542-199901000-00017","article-title":"Reducing myoclonus after etomidate","volume":"90","author":"Doenicke","year":"1999","journal-title":"Anesthesiology"},{"key":"10.1124\/jpet.117.245332_bib18","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/0960-0760(94)90267-4","article-title":"Therapy of Cushing\u2019s syndrome with steroid biosynthesis inhibitors","volume":"49","author":"Engelhardt","year":"1994","journal-title":"J Steroid Biochem Mol Biol"},{"issue":"Suppl 3","key":"10.1124\/jpet.117.245332_bib19","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1046\/j.1365-2362.2000.0300s3076.x","article-title":"New mechanisms of adrenostatic compounds in a human adrenocortical cancer cell line","volume":"30","author":"Fassnacht","year":"2000","journal-title":"Eur J Clin Invest"},{"key":"10.1124\/jpet.117.245332_bib20","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1007\/s11102-016-0742-1","article-title":"Updates on the role of adrenal steroidogenesis inhibitors in Cushing\u2019s syndrome: a focus on novel therapies","volume":"19","author":"Fleseriu","year":"2016","journal-title":"Pituitary"},{"key":"10.1124\/jpet.117.245332_bib21","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1097\/MED.0b013e328248b498","article-title":"Second-line treatment for Cushing\u2019s disease when initial pituitary surgery is unsuccessful","volume":"14","author":"Fleseriu","year":"2007","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"key":"10.1124\/jpet.117.245332_bib22","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1007\/s11102-012-0397-5","article-title":"Medical management of Cushing\u2019s disease: what is the future?","volume":"15","author":"Fleseriu","year":"2012","journal-title":"Pituitary"},{"key":"10.1124\/jpet.117.245332_bib23","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1097\/ALN.0b013e3181ff72b5","article-title":"Clinical and molecular pharmacology of etomidate","volume":"114","author":"Forman","year":"2011","journal-title":"Anesthesiology"},{"issue":"Suppl 1","key":"10.1124\/jpet.117.245332_bib24","first-page":"S72","article-title":"Molecular targets underlying general anaesthesia","volume":"147","author":"Franks","year":"2006","journal-title":"Br J Pharmacol"},{"key":"10.1124\/jpet.117.245332_bib25","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1111\/j.1365-2265.1984.tb00112.x","article-title":"The inhibition by etomidate of the 11 \u03b2-hydroxylation of cortisol","volume":"20","author":"Fry","year":"1984","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1124\/jpet.117.245332_bib26","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/cen.12345","article-title":"Efficacy of medical treatment in Cushing\u2019s disease: a systematic review","volume":"80","author":"Gadelha","year":"2014","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1124\/jpet.117.245332_bib27","doi-asserted-by":"crossref","first-page":"962","DOI":"10.4158\/EP171787.OR","article-title":"Biochemical control during long-term follow-up of 230 adult patients with Cushing disease: a Multicenter Retrospective Study","volume":"23","author":"Geer","year":"2017","journal-title":"Endocr Pract"},{"key":"10.1124\/jpet.117.245332_bib28","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1213\/00000539-198509000-00006","article-title":"Etomidate versus thiopental for induction of anesthesia","volume":"64","author":"Giese","year":"1985","journal-title":"Anesth Analg"},{"key":"10.1124\/jpet.117.245332_bib29","first-page":"386","article-title":"Mitotane for adrenocortical carcinoma treatment","volume":"6","author":"Hahner","year":"2005","journal-title":"Curr Opin Investig Drugs"},{"key":"10.1124\/jpet.117.245332_bib30","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1055\/s-0030-1249629","article-title":"Etomidate unmasks intraadrenal regulation of steroidogenesis and proliferation in adrenal cortical cell lines","volume":"42","author":"Hahner","year":"2010","journal-title":"Horm Metab Res"},{"key":"10.1124\/jpet.117.245332_bib31","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1096\/fj.02-0611fje","article-title":"General anesthetic actions in vivo strongly attenuated by a point mutation in the GABA(A) receptor \u03b23 subunit","volume":"17","author":"Jurd","year":"2003","journal-title":"FASEB J"},{"key":"10.1124\/jpet.117.245332_bib32","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/j.gie.2017.02.033","article-title":"Etomidate versus propofol sedation for complex upper endoscopic procedures: a prospective double-blinded randomized controlled trial","volume":"86","author":"Kim","year":"2017","journal-title":"Gastrointest Endosc"},{"key":"10.1124\/jpet.117.245332_bib33","first-page":"4104","article-title":"Use of a parenteral propylene glycol-containing etomidate preparation for the long-term management of ectopic Cushing\u2019s syndrome","volume":"86","author":"Krakoff","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1124\/jpet.117.245332_bib34","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1016\/S0140-6736(14)61375-1","article-title":"Cushing\u2019s syndrome","volume":"386","author":"Lacroix","year":"2015","journal-title":"Lancet"},{"key":"10.1124\/jpet.117.245332_bib35","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1177\/000456328602300301","article-title":"On the assessment of the in vitro biopotency and site(s) of action of drugs affecting adrenal steroidogenesis","volume":"23","author":"Lambert","year":"1986","journal-title":"Ann Clin Biochem"},{"key":"10.1124\/jpet.117.245332_bib36","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/S0022-3565(25)22688-X","article-title":"Differential effects of the imidazole derivatives etomidate, ketoconazole and miconazole and of metyrapone on the secretion of cortisol and its precursors by human adrenocortical cells","volume":"240","author":"Lamberts","year":"1987","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.117.245332_bib37","first-page":"49","article-title":"The protracted effect of o,p\u2032-DDD in Cushing\u2019s disease and its impact on adrenal morphogenesis of young human embryo","volume":"50","author":"Leiba","year":"1989","journal-title":"Ann Endocrinol (Paris)"},{"key":"10.1124\/jpet.117.245332_bib38","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1056\/NEJM197903013000903","article-title":"Treatment of Cushing\u2019s disease by O,p\u2019DDD. Survey of 62 cases","volume":"300","author":"Luton","year":"1979","journal-title":"N Engl J Med"},{"key":"10.1124\/jpet.117.245332_bib39","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1111\/j.1365-2265.2004.02168.x","article-title":"High cardiovascular risk in patients with Cushing\u2019s syndrome according to 1999 WHO\/ISH guidelines","volume":"61","author":"Mancini","year":"2004","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1124\/jpet.117.245332_bib40","first-page":"433","article-title":"Pro- and anticonvulsant effects of anesthetics (Part II)","volume":"70","author":"Modica","year":"1990","journal-title":"Anesth Analg"},{"key":"10.1124\/jpet.117.245332_bib41","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1210\/jc.2007-2013","article-title":"Late recurrences of Cushing\u2019s disease after initial successful transsphenoidal surgery","volume":"93","author":"Patil","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1124\/jpet.117.245332_bib42","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1213\/ANE.0b013e3182320559","article-title":"In vivo and in vitro pharmacological studies of methoxycarbonyl-carboetomidate","volume":"115","author":"Pejo","year":"2012","journal-title":"Anesth Analg"},{"key":"10.1124\/jpet.117.245332_bib43","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1097\/ALN.0000000000000268","article-title":"Analogues of etomidate: modifications around etomidate\u2019s chiral carbon and the impact on in vitro and in vivo pharmacology","volume":"121","author":"Pejo","year":"2014","journal-title":"Anesthesiology"},{"key":"10.1124\/jpet.117.245332_bib44","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1097\/ALN.0000000000001304","article-title":"Sedative-hypnotic binding to 11\u03b2-hydroxylase","volume":"125","author":"Pejo","year":"2016","journal-title":"Anesthesiology"},{"key":"10.1124\/jpet.117.245332_bib45","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1210\/er.2013-1048","article-title":"The treatment of Cushing\u2019s disease","volume":"36","author":"Pivonello","year":"2015","journal-title":"Endocr Rev"},{"key":"10.1124\/jpet.117.245332_bib46","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1007\/s12020-016-0984-8","article-title":"Cushing\u2019s disease: the burden of illness","volume":"56","author":"Pivonello","year":"2017","journal-title":"Endocrine"},{"key":"10.1124\/jpet.117.245332_bib47","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/S2213-8587(16)00086-3","article-title":"Complications of Cushing\u2019s syndrome: state of the art","volume":"4","author":"Pivonello","year":"2016","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1124\/jpet.117.245332_bib48","doi-asserted-by":"crossref","first-page":"2150","DOI":"10.1001\/archinte.1984.04400020052007","article-title":"High-dose ketoconazole therapy and adrenal and testicular function in humans","volume":"144","author":"Pont","year":"1984","journal-title":"Arch Intern Med"},{"key":"10.1124\/jpet.117.245332_bib49","doi-asserted-by":"crossref","first-page":"2137","DOI":"10.1001\/archinte.1982.00340250097015","article-title":"Ketoconazole blocks testosterone synthesis","volume":"142","author":"Pont","year":"1982","journal-title":"Arch Intern Med"},{"key":"10.1124\/jpet.117.245332_bib50","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1530\/EJE-12-0274","article-title":"Etomidate in the management of hypercortisolaemia in Cushing\u2019s syndrome: a review","volume":"167","author":"Preda","year":"2012","journal-title":"Eur J Endocrinol"},{"key":"10.1124\/jpet.117.245332_bib51","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1210\/jcem-70-5-1426","article-title":"Infusion of low dose etomidate: correction of hypercortisolemia in patients with Cushing\u2019s syndrome and dose-response relationship in normal subjects","volume":"70","author":"Schulte","year":"1990","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1124\/jpet.117.245332_bib52","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1213\/ANE.0b013e31828b3637","article-title":"Carboetomidate: an analog of etomidate that interacts weakly with 11\u03b2-hydroxylase","volume":"116","author":"Shanmugasundararaj","year":"2013","journal-title":"Anesth Analg"},{"key":"10.1124\/jpet.117.245332_bib53","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1111\/j.1365-2265.1991.tb03547.x","article-title":"Ketoconazole treatment in Cushing\u2019s syndrome: experience in 34 patients","volume":"35","author":"Sonino","year":"1991","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1124\/jpet.117.245332_bib54","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/B978-0-444-59602-4.00015-0","article-title":"Cushing\u2019s disease","volume":"124","author":"Tritos","year":"2014","journal-title":"Handb Clin Neurol"},{"key":"10.1124\/jpet.117.245332_bib55","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1007\/s11060-013-1269-1","article-title":"Medical management of Cushing\u2019s disease","volume":"117","author":"Tritos","year":"2014","journal-title":"J Neurooncol"},{"key":"10.1124\/jpet.117.245332_bib56","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1111\/cen.13414","article-title":"A polymorphism in the CYP17A1 gene influences the therapeutic response to steroidogenesis inhibitors in Cushing\u2019s syndrome","volume":"87","author":"Valassi","year":"2017","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1124\/jpet.117.245332_bib57","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/S0022-3565(25)29374-0","article-title":"On biological assays involving quantal responses","volume":"183","author":"Waud","year":"1972","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.117.245332_bib58","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/0022-4731(73)90033-2","article-title":"Complexing of DDT and o,p\u2019DDD with adrenal cytochrome P-450 hydroxylating systems","volume":"4","author":"Young","year":"1973","journal-title":"J Steroid Biochem"},{"key":"10.1124\/jpet.117.245332_bib59","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1124\/dmd.30.3.314","article-title":"Inhibition of cytochromes P450 by antifungal imidazole derivatives","volume":"30","author":"Zhang","year":"2002","journal-title":"Drug Metab Dispos"}],"container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002235652426153X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002235652426153X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/jpet.117.245332","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T19:57:45Z","timestamp":1739995065000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S002235652426153X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2]]},"references-count":59,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2018,2]]}},"alternative-id":["S002235652426153X"],"URL":"https:\/\/doi.org\/10.1124\/jpet.117.245332","relation":{},"ISSN":["0022-3565"],"issn-type":[{"value":"0022-3565","type":"print"}],"subject":[],"published":{"date-parts":[[2018,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Dimethoxy-etomidate: A Nonhypnotic Etomidate Analog that Potently Inhibits Steroidogenesis","name":"articletitle","label":"Article Title"},{"value":"The Journal of Pharmacology and Experimental Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/jpet.117.245332","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 by The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}